Differential effects of glycolipid biosynthesis inhibitors on ceramide- induced cell death in neuroblastoma cells

Erhard Bieberich, Bettina Freischütz, Minoru Suzuki, Robert K Yu

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

An in vitro model of Gaucher's disease in murine neuroblastoma X rat glioma NG108-15 cells was used to investigate the physiological effects of two specific inhibitors of glucosylceramide synthase, d,l-threo-1-phenyl-2- decanoylamino-3-morpholino-1-propanol (d,l-PDMP) and N-butyldeoxynojirimycin (NB-DNJ), which have been suggested as agents for treatment of glycolipid storage disorders. Incubation of NG108-15 cells with conduritol-B-epoxide, a covalent inhibitor of glucosylceramidase, raised the intracellular concentration of glucosylceramide (GC) by more than fourfold, indicating a glycolipid composition equivalent to that of Gaucher's cells. The level of GC was decreased, and the cells were depleted of gangliosides by postincubation with d,l-PDMP or NB-DNJ. Treatment with d,l-PDMP, but not with NB-DNJ, resulted in a dose-dependent reduction of the growth rate and eventually caused cell death in NG108-15 cells on reaching confluency. An in situ detection assay using terminal nucleotidyltransferase indicated that cell degeneration was accompanied by apoptosis. Lipid analysis by high-performance TLC revealed that on incubation with d,l-PDMP, but not with NB-DNJ, the concentration of endogenous ceramide was elevated by threefold. Ceramide elevation and apoptosis were also observed when NG108-15 cells were incubated with daunorubicin, which was previously reported to induce programmed cell death by stimulation of ceramide synthesis. Structural characterization by HPLC and subsequent laser desorption mass spectrometry revealed that the endogenous ceramide contained fatty acids with chain lengths ranging from C14:0 to C24:0. The results indicate that elevation of levels of these ceramide species by incubation with d,l-PDMP or daunorubicin induces programmed cell death in NG108-15 cells. Because ceramide accumulation and cell death were not observed on incubation with NB-DNJ, its use is suggested to be less toxic than that of d,l-PDMP for treatment of Gaucher's disease and other sphingolipid storage disorders.

Original languageEnglish (US)
Pages (from-to)1040-1049
Number of pages10
JournalJournal of Neurochemistry
Volume72
Issue number3
DOIs
StatePublished - Feb 24 1999

Fingerprint

Ceramides
Glycolipids
Biosynthesis
Cell death
Neuroblastoma
Cell Death
Glucosylceramides
Daunorubicin
ceramide glucosyltransferase
Gaucher Disease
Nucleotidyltransferases
Glucosylceramidase
Apoptosis
Sphingolipids
Gangliosides
Poisons
Chain length
Mass spectrometry
RV 538
Rats

Keywords

  • Apoptosis
  • Cell death
  • Gaucher's disease
  • Glycolipids
  • Neuroblastoma cells

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Differential effects of glycolipid biosynthesis inhibitors on ceramide- induced cell death in neuroblastoma cells. / Bieberich, Erhard; Freischütz, Bettina; Suzuki, Minoru; Yu, Robert K.

In: Journal of Neurochemistry, Vol. 72, No. 3, 24.02.1999, p. 1040-1049.

Research output: Contribution to journalArticle

Bieberich, Erhard ; Freischütz, Bettina ; Suzuki, Minoru ; Yu, Robert K. / Differential effects of glycolipid biosynthesis inhibitors on ceramide- induced cell death in neuroblastoma cells. In: Journal of Neurochemistry. 1999 ; Vol. 72, No. 3. pp. 1040-1049.
@article{9a0a6f82963645c5ac501462d13a65f4,
title = "Differential effects of glycolipid biosynthesis inhibitors on ceramide- induced cell death in neuroblastoma cells",
abstract = "An in vitro model of Gaucher's disease in murine neuroblastoma X rat glioma NG108-15 cells was used to investigate the physiological effects of two specific inhibitors of glucosylceramide synthase, d,l-threo-1-phenyl-2- decanoylamino-3-morpholino-1-propanol (d,l-PDMP) and N-butyldeoxynojirimycin (NB-DNJ), which have been suggested as agents for treatment of glycolipid storage disorders. Incubation of NG108-15 cells with conduritol-B-epoxide, a covalent inhibitor of glucosylceramidase, raised the intracellular concentration of glucosylceramide (GC) by more than fourfold, indicating a glycolipid composition equivalent to that of Gaucher's cells. The level of GC was decreased, and the cells were depleted of gangliosides by postincubation with d,l-PDMP or NB-DNJ. Treatment with d,l-PDMP, but not with NB-DNJ, resulted in a dose-dependent reduction of the growth rate and eventually caused cell death in NG108-15 cells on reaching confluency. An in situ detection assay using terminal nucleotidyltransferase indicated that cell degeneration was accompanied by apoptosis. Lipid analysis by high-performance TLC revealed that on incubation with d,l-PDMP, but not with NB-DNJ, the concentration of endogenous ceramide was elevated by threefold. Ceramide elevation and apoptosis were also observed when NG108-15 cells were incubated with daunorubicin, which was previously reported to induce programmed cell death by stimulation of ceramide synthesis. Structural characterization by HPLC and subsequent laser desorption mass spectrometry revealed that the endogenous ceramide contained fatty acids with chain lengths ranging from C14:0 to C24:0. The results indicate that elevation of levels of these ceramide species by incubation with d,l-PDMP or daunorubicin induces programmed cell death in NG108-15 cells. Because ceramide accumulation and cell death were not observed on incubation with NB-DNJ, its use is suggested to be less toxic than that of d,l-PDMP for treatment of Gaucher's disease and other sphingolipid storage disorders.",
keywords = "Apoptosis, Cell death, Gaucher's disease, Glycolipids, Neuroblastoma cells",
author = "Erhard Bieberich and Bettina Freisch{\"u}tz and Minoru Suzuki and Yu, {Robert K}",
year = "1999",
month = "2",
day = "24",
doi = "10.1046/j.1471-4159.1999.0721040.x",
language = "English (US)",
volume = "72",
pages = "1040--1049",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Differential effects of glycolipid biosynthesis inhibitors on ceramide- induced cell death in neuroblastoma cells

AU - Bieberich, Erhard

AU - Freischütz, Bettina

AU - Suzuki, Minoru

AU - Yu, Robert K

PY - 1999/2/24

Y1 - 1999/2/24

N2 - An in vitro model of Gaucher's disease in murine neuroblastoma X rat glioma NG108-15 cells was used to investigate the physiological effects of two specific inhibitors of glucosylceramide synthase, d,l-threo-1-phenyl-2- decanoylamino-3-morpholino-1-propanol (d,l-PDMP) and N-butyldeoxynojirimycin (NB-DNJ), which have been suggested as agents for treatment of glycolipid storage disorders. Incubation of NG108-15 cells with conduritol-B-epoxide, a covalent inhibitor of glucosylceramidase, raised the intracellular concentration of glucosylceramide (GC) by more than fourfold, indicating a glycolipid composition equivalent to that of Gaucher's cells. The level of GC was decreased, and the cells were depleted of gangliosides by postincubation with d,l-PDMP or NB-DNJ. Treatment with d,l-PDMP, but not with NB-DNJ, resulted in a dose-dependent reduction of the growth rate and eventually caused cell death in NG108-15 cells on reaching confluency. An in situ detection assay using terminal nucleotidyltransferase indicated that cell degeneration was accompanied by apoptosis. Lipid analysis by high-performance TLC revealed that on incubation with d,l-PDMP, but not with NB-DNJ, the concentration of endogenous ceramide was elevated by threefold. Ceramide elevation and apoptosis were also observed when NG108-15 cells were incubated with daunorubicin, which was previously reported to induce programmed cell death by stimulation of ceramide synthesis. Structural characterization by HPLC and subsequent laser desorption mass spectrometry revealed that the endogenous ceramide contained fatty acids with chain lengths ranging from C14:0 to C24:0. The results indicate that elevation of levels of these ceramide species by incubation with d,l-PDMP or daunorubicin induces programmed cell death in NG108-15 cells. Because ceramide accumulation and cell death were not observed on incubation with NB-DNJ, its use is suggested to be less toxic than that of d,l-PDMP for treatment of Gaucher's disease and other sphingolipid storage disorders.

AB - An in vitro model of Gaucher's disease in murine neuroblastoma X rat glioma NG108-15 cells was used to investigate the physiological effects of two specific inhibitors of glucosylceramide synthase, d,l-threo-1-phenyl-2- decanoylamino-3-morpholino-1-propanol (d,l-PDMP) and N-butyldeoxynojirimycin (NB-DNJ), which have been suggested as agents for treatment of glycolipid storage disorders. Incubation of NG108-15 cells with conduritol-B-epoxide, a covalent inhibitor of glucosylceramidase, raised the intracellular concentration of glucosylceramide (GC) by more than fourfold, indicating a glycolipid composition equivalent to that of Gaucher's cells. The level of GC was decreased, and the cells were depleted of gangliosides by postincubation with d,l-PDMP or NB-DNJ. Treatment with d,l-PDMP, but not with NB-DNJ, resulted in a dose-dependent reduction of the growth rate and eventually caused cell death in NG108-15 cells on reaching confluency. An in situ detection assay using terminal nucleotidyltransferase indicated that cell degeneration was accompanied by apoptosis. Lipid analysis by high-performance TLC revealed that on incubation with d,l-PDMP, but not with NB-DNJ, the concentration of endogenous ceramide was elevated by threefold. Ceramide elevation and apoptosis were also observed when NG108-15 cells were incubated with daunorubicin, which was previously reported to induce programmed cell death by stimulation of ceramide synthesis. Structural characterization by HPLC and subsequent laser desorption mass spectrometry revealed that the endogenous ceramide contained fatty acids with chain lengths ranging from C14:0 to C24:0. The results indicate that elevation of levels of these ceramide species by incubation with d,l-PDMP or daunorubicin induces programmed cell death in NG108-15 cells. Because ceramide accumulation and cell death were not observed on incubation with NB-DNJ, its use is suggested to be less toxic than that of d,l-PDMP for treatment of Gaucher's disease and other sphingolipid storage disorders.

KW - Apoptosis

KW - Cell death

KW - Gaucher's disease

KW - Glycolipids

KW - Neuroblastoma cells

UR - http://www.scopus.com/inward/record.url?scp=0033005150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033005150&partnerID=8YFLogxK

U2 - 10.1046/j.1471-4159.1999.0721040.x

DO - 10.1046/j.1471-4159.1999.0721040.x

M3 - Article

C2 - 10037475

AN - SCOPUS:0033005150

VL - 72

SP - 1040

EP - 1049

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -